Number of eligible clients: CDEC talked over the uncertainty in the amount of sufferers with reasonably intense to extreme hemophilia B in Canada qualified for etranacogene dezaparvovec. Scientific gurus consulted by CADTH indicated that some patients who are categorized as possessing gentle or moderate ailment can have a critical bleeding phenotyp… Read More